Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine

Moderna may seek the FDA’s accelerated approval for its personalized cancer vaccine, the company’s president, Stephen Hoge, said Monday at Cowen’s 43rd Annual Healthcare Conference in Boston.